EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer

Kevin J. Lee(University of Alabama at Birmingham), Natalie R. Gassman(University of Alabama at Birmingham), Griffin Wright(USA Mitchell Cancer Institute), Michele A. Schuler(University of South Alabama), Hannah Bryant(University of South Alabama), Leigh Ann Wiggins(University of South Alabama)
Cancer Drug Resistance
January 1, 2021
Cited by 11


Related Papers